Hyalofast
Device musculoskeletal
General payments
$136,857
Research payments
$71,747
Through program year 2024, $136,857 in general payments and $71,747 in research payments were reported against Hyalofast (musculoskeletal).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $41,840 | 9 |
| 2023 | General | $21,450 | 4 |
| 2023 | Research | $71,747 | 11 |
| 2022 | General | $48,067 | 3 |
| 2020 | General | $25,500 | 5 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
21 general · 11 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.